azetidin-3-yl(pyrrolidin-1-yl)methanone hydrochloride, 95.0%, 250mg

2,3-Dihydro-benzo[1,4]dioxine-2-carboxylic acidethyl ester, 95.0%, 25g

(R)-4-Phenyl-2-(2-((S)-p-tolylsulfinyl)phenyl)-4,5-dihydrooxazole, 98%, 1g

1-methyl-3-phenyl-1H-pyrazole, 100mg

METHYL 6-BROMO-3-METHYL-1H-INDOLE-4-CARBOXYLATE, 95.0%, 500mg

3-Bromo-5-nitrosalicylaldehyde>95.0%(GC)(T)5g

((3aR,4R,6R,6aR)-6-((E)-4-(Hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl isobutyrate, 97%, 5g

4-METHYL-2-(METHYLAMINO)THIAZOLE-5-SULFONAMIDE, 95.0%, 500mg

2,6-Dibromobenzyl acetate, 95.0%, 250mg

p-(Octyloxyphenyl)phenyliodonium hexafluor antimonate, 25g

2,6-Dichloropyridine-3-boronic acid, 97.0%, 10g

Tert-butyl3-ethynylazepane-1-carboxylate, 98%, 100mg

4,4,5,5-Tetramethyl-2-(4-(methylsulfinyl)phenyl)-1,3,2-dioxaborolane, 95.0%, 100mg